Walgreens Boots Alliance Shares - weekly outlook amid delisting status
20.06.2026 - 22:58:56 | ad-hoc-news.de
Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 20:57 UTC. Details in the imprint.
Walgreens Boots Alliance (US92939U1060) sits in quiet-day mode today. A live market page flags the stock as potentially delisted and says it may not be actively trading.
What the live market page shows
The only live-verifiable market cue in the provided search results comes from MarketBeat, which labels Walgreens Boots Alliance as potentially delisted. The page also lists NASDAQ:WBA with a last quoted range around $11.98 to $11.985. MarketBeat quote page
Because no Reuters, IR, analyst, or filing item is live-verified here, the article cannot use a dated corporate hook. The Saturday focus therefore stays on the weekly setup rather than a fresh event.
Saturday business lens
On Saturdays, the weekday module shifts to the company’s broader business model and long-term setup. For Walgreens Boots Alliance, that means a retail pharmacy and health-services group with a large U.S. store base and international operations.
No fresh operational update was live-verified in the provided results. That leaves only the longer-running context around the business model and the market’s current handling of the quote.
What the company sells
Walgreens Boots Alliance operates retail pharmacies, prescription fulfillment, and consumer health and wellness products. Its core business centers on pharmacy dispensing, front-end retail, and related healthcare services.
Where the stock trades today
The shares of Walgreens Boots Alliance (US92939U1060) trade on Nasdaq at about $11.98 as of 06/20/2026, 20:57 UTC.
Walgreens Boots Alliance at a glance
- Company: Walgreens Boots Alliance, Inc.
- ISIN: US92939U1060
- Ticker: WBA
- Venue: Nasdaq
- Price (as of 06/20/2026, 20:57 UTC): $11.98
- Sector / Industry: Consumer Staples / Drug Retail
- Index membership: not live-verifiable
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
